K-Stock Briefing - Page 185 of 230 - https://kstockbriefing.com

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-14

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-14

Semiconductors

[Disclosure] Hana Micron (067310) – Additional Listing (Public Offering of Forfeited Shares After Shareholder Rights Offering) / 2024-08-14

[Disclosure] Hana Micron (067310) – Additional Listing (Public Offering of Forfeited Shares After Shareholder Rights Offering) / 2024-08-14

Semiconductors

[Disclosure] SK Square (402340) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

[Disclosure] SK Square (402340) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

Semiconductors

[Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14

[Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14

Semiconductors

[Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

[Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

Disclosures

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14

Disclosures

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-08-14

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-08-14

Disclosures

[Disclosure] Jusung Engineering (036930) – (Correction) Sales and Supply Contract / 2024-08-14

[Disclosure] Jusung Engineering (036930) – (Correction) Sales and Supply Contract / 2024-08-14

Semiconductors

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-08-12

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-08-12

Disclosures

[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-08-09

[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-08-09

Disclosures